Market Place
Sourcing Support
Flare Therapeutics Enters Discovery Collaboration with Roche
14 Nov 2024 //
BUSINESSWIRE
Roche stakes over $1.8B on cancer-linked transcription factors
13 Nov 2024 //
BIOSPACE
Flare Therapeutics Partners with Roche to Target Transcription Factors
12 Nov 2024 //
PR NEWSWIRE
Genentech axes Nykode cancer vaccine deal
09 Nov 2024 //
FIERCE BIOTECH
Vaccinex Reports Immunity Benefit with Pepinemab at SITC Meeting
05 Nov 2024 //
GLOBENEWSWIRE
Roche Presents Long-Term Data Across Hematology Portfolio at ASH
05 Nov 2024 //
GLOBENEWSWIRE
Genentech to Share Long-term Data at ASH 2024 Hematology
05 Nov 2024 //
BUSINESSWIRE
PredicineCARE Featured in NEJM for Roche’s Ph 3 Breast Cancer Trial
04 Nov 2024 //
GLOBENEWSWIRE
UCB`s tau drug flunks Alzheimer`s trial days after Roche`s exit
01 Nov 2024 //
FIERCE BIOTECH
Roche collects more data on blood tests for Alzheimer’s disease
31 Oct 2024 //
FIERCE BIOTECH
Vaccinex Reports SIGNAL-AD Data for Pepinemab at CTAD
31 Oct 2024 //
GLOBENEWSWIRE
Publishes Ph 3 Results for Roche’s Itovebi in HR+ve Breast Cancer
31 Oct 2024 //
GLOBENEWSWIRE
Roche Presents Alzheimer’s Diagnostics Data at CTAD
31 Oct 2024 //
GLOBENEWSWIRE
Patient death prompts Roche to adjust Alzheimer`s trial
31 Oct 2024 //
FIERCE PHARMA
High Court reinstates Injunction stopping sale of Zydus’ Sigrima
29 Oct 2024 //
EXPRESSPHARMA
Roche bets up to $1B to expand Dyno gene therapy delivery pact
25 Oct 2024 //
FIERCE BIOTECH
Roche`s Vabysmo will rise above Eylea biosim threat, exec says
24 Oct 2024 //
FIERCE PHARMA
CDC revamps last year`s `Wild to Mild` flu vaccine campaign
24 Oct 2024 //
FIERCE PHARMA
Roche culls cough candidate, pivots KRAS after revaluing pipeline
24 Oct 2024 //
FIERCE BIOTECH
Roche CEO critiques Novo`s proposed Catalent buyout
23 Oct 2024 //
FIERCE PHARMA
Roche Reports 9% Sales Growth In Q3 2024
23 Oct 2024 //
GLOBENEWSWIRE
Roche CEO Says Closing Novo-Catalent Deal Would Be Wrong Decision
23 Oct 2024 //
ENDPTS
Roche tosses out $120M tau prospect, returning rights to UCB
23 Oct 2024 //
FIERCE BIOTECH
Roche CEO says more people have mpox in Europe than has been reported
22 Oct 2024 //
REUTERS
Roche comes out against takeover of manufacturer Catalent
22 Oct 2024 //
REUTERS
Roche’s Alecensa receives NICE to treat ALK-positive lung cancer
22 Oct 2024 //
PMLIVE
Roche’s Vabysmo Improves Vision In DME Underrepresented Groups
19 Oct 2024 //
INDPHARMAPOST
Roche MAGE-A4 trial withdrawn after strategic review
19 Oct 2024 //
FIERCE BIOTECH
Roche Gets FDA Approval For Companion Diagnostic For Vyloy
18 Oct 2024 //
PR NEWSWIRE
Roche’s Vabysmo Improves Vision In Underrepresented DME Groups.
18 Oct 2024 //
GLOBENEWSWIRE
Noema ticks off phase 2a Tourette win for ex-Roche molecule
17 Oct 2024 //
FIERCE BIOTECH
Roche`s Evrysdi Shows Positive Results In Children With SMA
14 Oct 2024 //
GLOBENEWSWIRE
Roche burnishes breast cancer portfolio with FDA nod for Itovebi
11 Oct 2024 //
FIERCE PHARMA
Tempest And Roche Agreement to Amezalpat For Hepatocellular Carcinoma
10 Oct 2024 //
GLOBENEWSWIRE
Roche Gets CE Certification For Gastric Cancer Companion Test
10 Oct 2024 //
GLOBENEWSWIRE
Clearside`s CLS-AX excels in phase 2b trial, set for phase 3
10 Oct 2024 //
FIERCE PHARMA
breast cancer pill could enter $12 bln market if trials succeed
09 Oct 2024 //
REUTERS
Lonza Completes Acquisition of Biologics Site from Roche
01 Oct 2024 //
CONTRACT PHARMA
Roche targets more than $3 billion in annual obesity sales
01 Oct 2024 //
REUTERS
Roche rolls out 12-virus diagnostic test in Europe
24 Sep 2024 //
FIERCE BIOTECH
Xofluza Reduces Influenza Transmission In Phase III Study
19 Sep 2024 //
GLOBENEWSWIRE
Boehringer`s Lung Fibrosis Trial Meets Primary Endpoint
17 Sep 2024 //
FIERCE BIOTECH
Roche`s Tecentriq Hybreza wins first FDA approval for a subcutaneous PD-L1 drug
14 Sep 2024 //
FIERCE PHARMA
FDA Approves Roche`s Subcutaneous OCREVUS ZUNOVO With ENHANZE
13 Sep 2024 //
PR NEWSWIRE
FDA Approves Roche`s Subcutaneous Cancer Immunotherapy Tecentriq Hybreza
13 Sep 2024 //
GLOBENEWSWIRE
Roche shares knocked by concern over side effects in obesity pill trial
13 Sep 2024 //
REUTERS
US FDA Withdraws Approval Of Roche`s Injectable Multiple Sclerosis Therapy
12 Sep 2024 //
REUTERS
Roche ramps up R&D with $1.4B Swiss facility
12 Sep 2024 //
FIERCE BIOTECH
Roche Opens Pharma R&D Center In Basel For Innovation
10 Sep 2024 //
GLOBENEWSWIRE
Genentech`s cancer restructure was made `for scientific reasons`: exec
10 Sep 2024 //
FIERCE BIOTECH
Roche`s Fenebrutinib Shows Promise In Multiple Sclerosis
04 Sep 2024 //
GLOBENEWSWIRE
Roche Touts Phase II MS Data on Heels of Sanofi’s Late-Stage Stumbles
04 Sep 2024 //
BIOSPACE
Roche`s Piasky (Crovalimab) Receives Approval in Europe
30 Aug 2024 //
EMA
Roche`s PiaSky Approved In EU As First Monthly Subcutaneous PNH Treatment
27 Aug 2024 //
INDIANPHARMAPOST
BioMarin Brings on Roche, Amgen Alums in Executive Restructuring
22 Aug 2024 //
BIOSPACE
Roche ramps up lab testing capacity for mpox worldwide following WHO declaration
21 Aug 2024 //
FIERCE BIOTECH
Roche Responds To WHO`s Mpox Global Health Emergency Declaration
20 Aug 2024 //
GLOBENEWSWIRE
Roche Regains Reputation Crown Among Rare Disease Patient Groups
20 Aug 2024 //
FIERCE PHARMA
Relay loses interest in SHP2 inhibitor after Genentech abandons collab
07 Aug 2024 //
FIERCE BIOTECH
Roche considering divesting $1.9 bln cancer data startup, FT reports
07 Aug 2024 //
REUTERS
